-
1
-
-
9244251125
-
Cell cycle checkpoints and cancer
-
Kastan MB, Bartek J. Cell cycle checkpoints and cancer. Nature 2004; 432:316-323
-
(2004)
Nature
, vol.432
, pp. 316-323
-
-
Kastan, M.B.1
Bartek, J.2
-
2
-
-
0027717617
-
P21 is a universal inhibitor of cyclin kinases
-
DOI 10.1038/366701a0
-
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-704 (Pubitemid 24036020)
-
(1993)
Nature
, vol.366
, Issue.6456
, pp. 701-704
-
-
Xiong, Y.1
Hannon, G.J.2
Zhang, H.3
Casso, D.4
Kobayashi, R.5
Beach, D.6
-
3
-
-
0027359827
-
WAF1, a potential mediator of p53 tumor suppression
-
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825
-
(1993)
Cell
, vol.75
, pp. 817-825
-
-
El-Deiry, W.S.1
Tokino, T.2
Velculescu, V.E.3
Levy, D.B.4
Parsons, R.5
Trent, J.M.6
-
4
-
-
0027731971
-
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
-
DOI 10.1038/366707a0
-
Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993; 366:707-710 (Pubitemid 24036022)
-
(1993)
Nature
, vol.366
, Issue.6456
, pp. 707-710
-
-
Gu, Y.1
Turck, C.W.2
Morgan, D.O.3
-
7
-
-
0033533612
-
14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage
-
Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401:616-620 (Pubitemid 129517080)
-
(1999)
Nature
, vol.401
, Issue.6753
, pp. 616-620
-
-
Chan, T.A.1
Hermeking, H.2
Lengauer, C.3
Kinzler, K.W.4
Vogelstein, B.5
-
8
-
-
0034725698
-
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression
-
DOI 10.1074/jbc.M905616199
-
Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106-23112 (Pubitemid 30646202)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.30
, pp. 23106-23112
-
-
Laronga, C.1
Yang, H.-Y.2
Neal, C.3
Lee, M.-H.4
-
9
-
-
36148996169
-
Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities
-
DOI 10.1038/sj.onc.1210540, PII 1210540
-
Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, et al. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene 2007; 26:7355-7362 (Pubitemid 350115974)
-
(2007)
Oncogene
, vol.26
, Issue.52
, pp. 7355-7362
-
-
Yang, H.-Y.1
Wen, Y.-Y.2
Lin, Y.-L.3
Pham, L.4
Su, C.-H.5
Yang, H.6
Chen, J.7
Lee, M.-H.8
-
10
-
-
41849147869
-
CARPs enhance p53 turnover by degrading 14-3-3sigma and stabilizing MDM2
-
Yang W, Dicker DT, Chen J, El-Deiry WS. CARPs enhance p53 turnover by degrading 14-3-3sigma and stabilizing MDM2. Cell Cycle 2008; 7:670-682
-
(2008)
Cell Cycle
, vol.7
, pp. 670-682
-
-
Yang, W.1
Dicker, D.T.2
Chen, J.3
El-Deiry, W.S.4
-
11
-
-
12944275670
-
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer
-
DOI 10.1073/pnas.100566997
-
Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, et al. High frequency of hypermethylation at the 14-3-3sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000; 97:6049-6054 (Pubitemid 30367521)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.11
, pp. 6049-6054
-
-
Ferguson, A.T.1
Evron, E.2
Umbricht, C.B.3
Pandita, T.K.4
Chan, T.A.5
Hermeking, H.6
Marks, J.R.7
Lambers, A.R.8
Futreal, P.A.9
Stampfer, M.R.10
Sukumar, S.11
-
12
-
-
16844374138
-
Frequent 14-3-3sigma promoter methylation in benign and malignant prostate lesions
-
DOI 10.1089/dna.2005.24.264
-
Henrique R, Jeronimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, et al. Frequent 14-3-3sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol 2005; 24:264-269 (Pubitemid 40490265)
-
(2005)
DNA and Cell Biology
, vol.24
, Issue.4
, pp. 264-269
-
-
Henrique, R.1
Jeronimo, C.2
Hoque, M.O.3
Carvalho, A.L.4
Oliveira, J.5
Teixeira, M.R.6
Lopes, C.7
Sidransky, D.8
-
13
-
-
34250160930
-
14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma
-
DOI 10.1016/j.humpath.2006.12.014, PII S0046817706007544
-
Kuroda Y, Aishima S, Taketomi A, Nishihara Y, Iguchi T, Taguchi K, et al. 14-3-3sigma negatively regulates the cell cycle, and its downregulation is associated with poor outcome in intrahepatic cholangiocarcinoma. Hum Pathol 2007; 38:1014-1022 (Pubitemid 46899146)
-
(2007)
Human Pathology
, vol.38
, Issue.7
, pp. 1014-1022
-
-
Kuroda, Y.1
Aishima, S.2
Taketomi, A.3
Nishihara, Y.4
Iguchi, T.5
Taguchi, K.6
Maehara, Y.7
Tsuneyoshi, M.8
-
14
-
-
0345059753
-
The 14-3-3 cancer connection
-
Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3:931-943
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 931-943
-
-
Hermeking, H.1
-
15
-
-
0034234211
-
Cooperative effects of genes controlling the G(2)/M checkpoint
-
Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 2000; 14:1584-1588
-
(2000)
Genes Dev
, vol.14
, pp. 1584-1588
-
-
Chan, T.A.1
Hwang, P.M.2
Hermeking, H.3
Kinzler, K.W.4
Vogelstein, B.5
-
16
-
-
0038418869
-
Chk1 and Chk2 kinases in checkpoint control and cancer
-
DOI 10.1016/S1535-6108(03)00110-7, PII S1535610803001107
-
Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003; 3:421-429 (Pubitemid 38340288)
-
(2003)
Cancer Cell
, vol.3
, Issue.5
, pp. 421-429
-
-
Bartek, J.1
Lukas, J.2
-
17
-
-
0037365789
-
ATM and related protein kinases: Safeguarding genome integrity
-
DOI 10.1038/nrc1011
-
Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3:155-168 (Pubitemid 37328868)
-
(2003)
Nature Reviews Cancer
, vol.3
, Issue.3
, pp. 155-168
-
-
Shiloh, Y.1
-
18
-
-
52449114574
-
Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer
-
Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9:759-769
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, pp. 759-769
-
-
Lavin, M.F.1
-
19
-
-
17644432403
-
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint
-
Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14:1448-1459
-
(2000)
Genes Dev
, vol.14
, pp. 1448-1459
-
-
Liu, Q.1
Guntuku, S.2
Cui, X.S.3
Matsuoka, S.4
Cortez, D.5
Tamai, K.6
-
20
-
-
33746495515
-
Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites
-
Durkin SG, Arlt MF, Howlett NG, Glover TW. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 2006; 25:4381-4388
-
(2006)
Oncogene
, vol.25
, pp. 4381-4388
-
-
Durkin, S.G.1
Arlt, M.F.2
Howlett, N.G.3
Glover, T.W.4
-
21
-
-
44149090307
-
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2 and caspase-3
-
Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R, et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2 and caspase-3. Cell 2008; 133:864-877
-
(2008)
Cell
, vol.133
, pp. 864-877
-
-
Sidi, S.1
Sanda, T.2
Kennedy, R.D.3
Hagen, A.T.4
Jette, C.A.5
Hoffmans, R.6
-
22
-
-
33749039966
-
The CHEK2 gene and inherited breast cancer susceptibility
-
DOI 10.1038/sj.onc.1209877, PII 1209877
-
Nevanlinna H, Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 2006; 25:5912-5919 (Pubitemid 44453447)
-
(2006)
Oncogene
, vol.25
, Issue.43
, pp. 5912-5919
-
-
Nevanlinna, H.1
Bartek, J.2
-
23
-
-
0036132065
-
Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung and ovarian tumors
-
Miller CW, Ikezoe T, Krug U, Hofmann WK, Tavor S, Vegesna V, et al. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung and ovarian tumors. Genes Chromosomes Cancer 2002; 33:17-21.
-
(2002)
Genes Chromosomes Cancer
, vol.33
, pp. 17-21
-
-
Miller, C.W.1
Ikezoe, T.2
Krug, U.3
Hofmann, W.K.4
Tavor, S.5
Vegesna, V.6
-
24
-
-
46149124528
-
Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage
-
DOI 10.1016/j.molcel.2008.04.028, PII S1097276508003389
-
Stracker TH, Couto SS, Cordon-Cardo C, Matos T, Petrini JH. Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage. Mol Cell 2008; 31:21-32. (Pubitemid 351905921)
-
(2008)
Molecular Cell
, vol.31
, Issue.1
, pp. 21-32
-
-
Stracker, T.H.1
Couto, S.S.2
Cordon-Cardo, C.3
Matos, T.4
Petrini, J.H.J.5
-
25
-
-
0032484084
-
Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
-
Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998; 282:1893-1897 (Pubitemid 28555269)
-
(1998)
Science
, vol.282
, Issue.5395
, pp. 1893-1897
-
-
Matsuoka, S.1
Huang, M.2
Elledge, S.J.3
-
26
-
-
0034629072
-
DNA damageinduced activation of p53 by the checkpoint kinase Chk2
-
Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, et al. DNA damageinduced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287:1824-1827
-
(2000)
Science
, vol.287
, pp. 1824-1827
-
-
Hirao, A.1
Kong, Y.Y.2
Matsuoka, S.3
Wakeham, A.4
Ruland, J.5
Yoshida, H.6
-
28
-
-
0033552873
-
A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase
-
DOI 10.1016/S0960-9822(99)80041-4
-
Blasina A, de Weyer IV, Laus MC, Luyten WH, Parker AE, McGowan CH. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr Biol 1999; 9:1-10. (Pubitemid 29045789)
-
(1999)
Current Biology
, vol.9
, Issue.1
, pp. 1-10
-
-
Blasina, A.1
Van De Weyer, I.2
Laus, M.C.3
Luyten, W.H.M.L.4
Parker, A.E.5
McGowan, C.H.6
-
29
-
-
0012966157
-
Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A
-
DOI 10.1016/S1535-6108(03)00048-5
-
Sorensen CS, Syljuasen RG, Falck J, Schroeder T, Ronnstrand L, Khanna KK, et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3:247-258 (Pubitemid 37443880)
-
(2003)
Cancer Cell
, vol.3
, Issue.3
, pp. 247-258
-
-
Sorensen, C.S.1
Syljuasen, R.G.2
Falck, J.3
Schroeder, T.4
Ronnstrand, L.5
Khanna, K.K.6
Zhou, B.-B.7
Bartek, J.8
Lukas, J.9
-
30
-
-
0035848819
-
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
-
DOI 10.1038/35071124
-
Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001; 410:842-847 (Pubitemid 32303786)
-
(2001)
Nature
, vol.410
, Issue.6830
, pp. 842-847
-
-
Falck, J.1
Mailand, N.2
Syljuasen, R.G.3
Bartek, J.4
Lukas, J.5
-
31
-
-
0032508504
-
Enhanced phosphorylation of p53 by ATM in response to DNA damage
-
DOI 10.1126/science.281.5383.1674
-
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281:1674-1677 (Pubitemid 28435583)
-
(1998)
Science
, vol.281
, Issue.5383
, pp. 1674-1677
-
-
Banin, S.1
Moyal, L.2
Shieh, S.-Y.3
Taya, Y.4
Anderson, C.W.5
Chessa, L.6
Smorodinsky, N.I.7
Prives, C.8
Reiss, Y.9
Shiloh, Y.10
Ziv, Y.11
-
32
-
-
0032508608
-
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
-
DOI 10.1126/science.281.5383.1677
-
Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281:1677-1679 (Pubitemid 28435584)
-
(1998)
Science
, vol.281
, Issue.5383
, pp. 1677-1679
-
-
Canman, C.E.1
Lim, D.-S.2
Cimprich, K.A.3
Taya, Y.4
Tamai, K.5
Sakaguchi, K.6
Appella, E.7
Kastan, M.B.8
Siliciano, J.D.9
-
33
-
-
0038054343
-
The Chk2 tumor suppressor is not required for p53 responses in human cancer cells
-
DOI 10.1074/jbc.M213159200
-
Jallepalli PV, Lengauer C, Vogelstein B, Bunz F. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J Biol Chem 2003; 278:20475-20479 (Pubitemid 36806343)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.23
, pp. 20475-20479
-
-
Jallepalli, P.V.1
Lengauer, C.2
Vogelsteint, B.3
Bunz, F.4
-
34
-
-
0038392762
-
Questioning the role of checkpoint kinase 2 in the p53 DNA damage response
-
DOI 10.1074/jbc.M213185200
-
Ahn J, Urist M, Prives C. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response. J Biol Chem 2003; 278:20480-20489 (Pubitemid 36806344)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.23
, pp. 20480-20489
-
-
Ahn, J.1
Urist, M.2
Prives, C.3
-
35
-
-
0034659341
-
Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice
-
Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T, et al. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev 2000; 14:1439-1447 (Pubitemid 30421837)
-
(2000)
Genes and Development
, vol.14
, Issue.12
, pp. 1439-1447
-
-
Takai, H.1
Tominaga, K.2
Motoyama, N.3
Minamishima, Y.A.4
Nagahama, H.5
Tsukiyama, T.6
Ikeda, K.7
Nakayama, K.8
Nakanishi, M.9
Nakayama, K.-I.10
-
37
-
-
0033621560
-
WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis
-
WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res 2000; 60:679-684
-
(2000)
Cancer Res
, vol.60
, pp. 679-684
-
-
Tian, H.1
Wittmack, E.K.2
Jorgensen, T.J.3
-
38
-
-
0028958705
-
Growth factor modulation of p53- Mediated growth arrest versus apoptosis
-
Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53- mediated growth arrest versus apoptosis. Genes Dev 1995; 9:600-611
-
(1995)
Genes Dev
, vol.9
, pp. 600-611
-
-
Canman, C.E.1
Gilmer, T.M.2
Coutts, S.B.3
Kastan, M.B.4
-
39
-
-
36448973875
-
CHK2 kinase: Cancer susceptibility and cancer therapy-two sides of the same coin?
-
Antoni L, Sodha N, Collins I, Garrett MD. CHK2 kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nat Rev Cancer 2007; 7:925-936
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 925-936
-
-
Antoni, L.1
Sodha, N.2
Collins, I.3
Garrett, M.D.4
-
40
-
-
0028849274
-
Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells
-
Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55:5187-5190
-
(1995)
Cancer Res
, vol.55
, pp. 5187-5190
-
-
Waldman, T.1
Kinzler, K.W.2
-
41
-
-
0034326802
-
Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation
-
Ahn JY, Schwarz JK, Piwnica-Worms H, Canman CE. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 2000; 60:5934-5936 (Pubitemid 30839616)
-
(2000)
Cancer Research
, vol.60
, Issue.21
, pp. 5934-5936
-
-
Ahn, J.-Y.1
Schwarz, J.K.2
Piwnica-Worms, H.3
Canman, C.E.4
-
42
-
-
16344381702
-
p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation
-
Ou YH, Chung PH, Sun TP, Shieh SY. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell 2005; 16:1684-1695
-
(2005)
Mol Biol Cell
, vol.16
, pp. 1684-1695
-
-
Ou, Y.H.1
Chung, P.H.2
Sun, T.P.3
Shieh, S.Y.4
-
43
-
-
0030011128
-
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
-
DOI 10.1038/381713a0
-
Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381:713-716 (Pubitemid 26196573)
-
(1996)
Nature
, vol.381
, Issue.6584
, pp. 713-716
-
-
Waldman, T.1
Lengauer, C.2
Kinzler, K.W.3
Vogelstein, B.4
-
44
-
-
33748636939
-
Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage
-
DOI 10.1128/MCB.00562-06
-
Pereg Y, Lam S, Teunisse A, Biton S, Meulmeester E, Mittelman L, et al. Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage. Mol Cell Biol 2006; 26:6819-6831 (Pubitemid 44387632)
-
(2006)
Molecular and Cellular Biology
, vol.26
, Issue.18
, pp. 6819-6831
-
-
Pereg, Y.1
Lam, S.2
Teunisse, A.3
Biton, S.4
Meulmeester, E.5
Mittelman, L.6
Buscemi, G.7
Okamoto, K.8
Taya, Y.9
Shiloh, Y.10
Jochemsen, A.G.11
-
45
-
-
20144371717
-
Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
-
DOI 10.1021/jm0495935
-
Arienti KL, Brunmark A, Axe FU, McClure K, Lee A, Blevitt J, et al. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem 2005; 48:1873-1885 (Pubitemid 40396318)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.6
, pp. 1873-1885
-
-
Arienti, K.L.1
Brunmark, A.2
Axe, F.U.3
McClure, K.4
Lee, A.5
Blevitt, J.6
Neff, D.K.7
Huang, L.8
Crawford, S.9
Pandit, C.R.10
Karlsson, L.11
Breitenbucher, J.G.12
-
46
-
-
62249140224
-
The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1
-
Yeh YH, Huang YF, Lin TY, Shieh SY. The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1. Oncogene 2009; 28:1366-1378
-
(2009)
Oncogene
, vol.28
, pp. 1366-1378
-
-
Yeh, Y.H.1
Huang, Y.F.2
Lin, T.Y.3
Shieh, S.Y.4
-
47
-
-
0033515426
-
Phosphorylation of histone H3 is required for proper chromosome condensation and segregation
-
Wei Y, Yu L, Bowen J, Gorovsky MA, Allis CD. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 1999; 97:99-109. (Pubitemid 29165893)
-
(1999)
Cell
, vol.97
, Issue.1
, pp. 99-109
-
-
Wei, Y.1
Yu, L.2
Bowen, J.3
Gorovsky, M.A.4
David Allis, C.5
-
48
-
-
0142136826
-
Requirement of the MRN complex for ATM activation by DNA damage
-
DOI 10.1093/emboj/cdg541
-
Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 2003; 22:5612-5621 (Pubitemid 37279970)
-
(2003)
EMBO Journal
, vol.22
, Issue.20
, pp. 5612-5621
-
-
Uziel, T.1
Lerenthal, Y.2
Moyal, L.3
Andegeko, Y.4
Mittelman, L.5
Shiloh, Y.6
-
49
-
-
3242891189
-
The Mre11 complex and the metabolism of chromosome breaks: The importance of communicating and holding things together
-
DOI 10.1016/j.dnarep.2004.03.014, PII S1568786404000734
-
Stracker TH, Theunissen JW, Morales M, Petrini JH. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair 2004; 3:845-854 (Pubitemid 38997926)
-
(2004)
DNA Repair
, vol.3
, Issue.8-9
, pp. 845-854
-
-
Stracker, T.H.1
Theunissen, J.-W.F.2
Morales, M.3
Petrini, J.H.J.4
-
50
-
-
0033806120
-
Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability
-
DOI 10.1128/MCB.20.20.7764-7772.2000
-
Dhar S, Squire JA, Hande MP, Wellinger RJ, Pandita TK. Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability. Mol Cell Biol 2000; 20:7764-7772 (Pubitemid 30736899)
-
(2000)
Molecular and Cellular Biology
, vol.20
, Issue.20
, pp. 7764-7772
-
-
Dhar, S.1
Squire, J.A.2
Hande, M.P.3
Wellinger, R.J.4
Pandita, T.K.5
-
51
-
-
0036570317
-
Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: Implications for the use of dendritic cells for therapy of gliomas
-
Yang T, Witham TF, Villa L, Erff M, Attanucci J, Watkins S, et al. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Cancer Res 2002; 62:2583-2591 (Pubitemid 34462738)
-
(2002)
Cancer Research
, vol.62
, Issue.9
, pp. 2583-2591
-
-
Yang, T.1
Witham, T.F.2
Villa, L.3
Erff, M.4
Attanucci, J.5
Watkins, S.6
Kondziolka, D.7
Okada, H.8
Pollack, I.F.9
Chambers, W.H.10
-
52
-
-
4544370140
-
14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation
-
DOI 10.1074/jbc.M401300200
-
Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D. 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation. J Biol Chem 2004; 279:34353-34360 (Pubitemid 39318060)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.33
, pp. 34353-34360
-
-
Zhang, Y.1
Karas, M.2
Zhao, H.3
Yakar, S.4
Leroith, D.5
-
53
-
-
53249134928
-
Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity
-
Lu S, Becker KA, Hagen MJ, Yan H, Roberts AL, Mathews LA, et al. Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology 2008; 149:4809-4820
-
(2008)
Endocrinology
, vol.149
, pp. 4809-4820
-
-
Lu, S.1
Becker, K.A.2
Hagen, M.J.3
Yan, H.4
Roberts, A.L.5
Mathews, L.A.6
-
55
-
-
0030987661
-
P53-independent induction of p21(WAF1/CIP1) expression in pericentral hepatocytes following carbon tetrachloride intoxication
-
Serfas MS, Goufman E, Feuerman MH, Gartel AL, Tyner AL. p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ 1997; 8:951-961 (Pubitemid 27388092)
-
(1997)
Cell Growth and Differentiation
, vol.8
, Issue.9
, pp. 951-961
-
-
Serfas, M.S.1
Goufman, E.2
Feuerman, M.H.3
Gartel, A.L.4
Tyner, A.L.5
-
56
-
-
0033566082
-
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
-
DOI 10.1038/sj.onc.1202925
-
Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999; 18:4047-4054 (Pubitemid 29363911)
-
(1999)
Oncogene
, vol.18
, Issue.28
, pp. 4047-4054
-
-
Chaturvedi, P.1
Eng, W.K.2
Zhu, Y.3
Mattern, M.R.4
Mishra, R.5
Hurle, M.R.6
Zhang, X.7
Annan, R.S.8
Lu, Q.9
Faucette, L.F.10
Scott, G.F.11
Li, X.12
Carr, S.A.13
Johnson, R.K.14
Winkler, J.D.15
Zhou, B.-B.S.16
-
57
-
-
0033621392
-
Substrate specificities and identification of putative substrates of ATM kinase family members
-
Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 1999; 274:37538-37543
-
(1999)
J Biol Chem
, vol.274
, pp. 37538-37543
-
-
Kim, S.T.1
Lim, D.S.2
Canman, C.E.3
Kastan, M.B.4
-
58
-
-
0036724625
-
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner
-
DOI 10.1128/MCB.22.18.6521-6532.2002
-
Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)- dependent and an ATM-independent manner. Mol Cell Biol 2002; 22:6521-6532 (Pubitemid 34940968)
-
(2002)
Molecular and Cellular Biology
, vol.22
, Issue.18
, pp. 6521-6532
-
-
Hirao, A.1
Cheung, A.2
Duncan, G.3
Girard, P.-M.4
Elia, A.J.5
Wakeham, A.6
Okada, H.7
Sarkissian, T.8
Wong, J.A.9
Sakai, T.10
De Stanchina, E.11
Bristow, R.G.12
Suda, T.13
Lowe, S.W.14
Jeggo, P.A.15
Elledge, S.J.16
Mak, T.W.17
-
59
-
-
18644375649
-
Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription
-
Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J 2002; 21:5195-5205
-
(2002)
EMBO J
, vol.21
, pp. 5195-5205
-
-
Takai, H.1
Naka, K.2
Okada, Y.3
Watanabe, M.4
Harada, N.5
Saito, S.6
-
60
-
-
8444252707
-
Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: Differential activity in cells expressing or not p53
-
Carrassa L, Broggini M, Erba E, Damia G. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53. Cell Cycle 2004; 3:1177-1181 (Pubitemid 40268636)
-
(2004)
Cell Cycle
, vol.3
, Issue.9
, pp. 1177-1181
-
-
Carrassa, L.1
Broggini, M.2
Erba, E.3
Damia, G.4
-
61
-
-
33947236863
-
14-3- 3sigma controls mitotic translation to facilitate cytokinesis
-
Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC, et al. 14-3- 3sigma controls mitotic translation to facilitate cytokinesis. Nature 2007; 446:329-332
-
(2007)
Nature
, vol.446
, pp. 329-332
-
-
Wilker, E.W.1
Van Vugt, M.A.2
Artim, S.A.3
Huang, P.H.4
Petersen, C.P.5
Reinhardt, H.C.6
-
64
-
-
48849109488
-
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
-
Paris R, Henry RE, Stephens SJ, McBryde M, Espinosa JM. Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation. Cell Cycle 2008; 7:2427-2433
-
(2008)
Cell Cycle
, vol.7
, pp. 2427-2433
-
-
Paris, R.1
Henry, R.E.2
Stephens, S.J.3
McBryde, M.4
Espinosa, J.M.5
-
66
-
-
0037415735
-
Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects
-
DOI 10.1093/emboj/cdg060
-
Zachos G, Rainey MD, Gillespie DA. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J 2003; 22:713-723 (Pubitemid 36193615)
-
(2003)
EMBO Journal
, vol.22
, Issue.3
, pp. 713-723
-
-
Zachos, G.1
Rainey, M.D.2
Gillespie, D.A.F.3
|